According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Both stocks are risky, but one is far less so. Investors seeking stocks with explosive growth potential should consider the ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
ZME Science on MSN
Scientists engineered a supercharged Quorn fungus that makes nearly double the protein
A team led by researchers at Jiangnan University removed two genes from the genome of Fusarium venenatum, the fungus used in ...
The CRISPR-Cas9 gene-editing tool is as much in the spotlight as it is under scrutiny. Researchers are eager to make genetic modifications to DNA across ...
Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback